EBIT at other companies
Other financials
Where this comes from
Calculated from Aura Biosciences, Inc.’s reported figures.
Plus components not separately reported this period.
The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aura Biosciences, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aura Biosciences, Inc.'s EBIT?
- Aura Biosciences, Inc. (AURA) reported EBIT of -$34.87M in Q1 2026.
- How has Aura Biosciences, Inc.'s EBIT changed year-over-year?
- Aura Biosciences, Inc.'s EBIT decreased by 20.1% year-over-year, from -$29.04M to -$34.87M.
- What is the long-term trend for Aura Biosciences, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s EBIT has grown at a 33.7% compound annual growth rate (CAGR), from -$35.25M to -$112.79M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.